S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
S&P 500   4,228.32 (-1.40%)
DOW   33,051.76 (-1.14%)
QQQ   355.59 (-1.57%)
AAPL   171.44 (-1.33%)
MSFT   314.30 (-2.33%)
META   300.95 (-1.91%)
GOOGL   132.79 (-1.03%)
AMZN   125.42 (-3.12%)
TSLA   245.03 (-2.61%)
NVDA   437.58 (-2.29%)
NIO   8.63 (-1.82%)
BABA   84.34 (-2.53%)
AMD   100.30 (-2.88%)
T   14.71 (+0.27%)
F   12.06 (-2.03%)
MU   67.82 (-0.21%)
CGC   0.67 (-8.98%)
GE   107.35 (-1.32%)
DIS   80.21 (-1.79%)
AMC   7.97 (-2.21%)
PFE   33.92 (-0.06%)
PYPL   57.55 (-1.72%)
NFLX   383.47 (+0.83%)
OTCMKTS:KHRNF

Khiron Life Sciences (KHRNF) Stock Forecast, Price & News

$0.01
0.00 (-14.63%)
(As of 10/2/2023 ET)
Compare
Today's Range
$0.0105
▼
$0.0120
50-Day Range
$0.0104
▼
$0.0170
52-Week Range
$0.01
▼
$0.13
Volume
59,587 shs
Average Volume
199,073 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest

KHRNF stock logo

About Khiron Life Sciences (OTCMKTS:KHRNF) Stock

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

KHRNF Price History

KHRNF Stock News Headlines

October 3, 2023 | americanbankingnews.com
Khiron Life Sciences Corp. (OTCMKTS:KHRNF) Sees Significant Decrease in Short Interest
July 11, 2023 | msn.com
Cannabis Stock Gainers And Losers From July 11, 2023
October 3, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
June 19, 2023 | sg.finance.yahoo.com
KHRNF - Khiron Life Sciences Corp.
June 5, 2023 | finanznachrichten.de
Khiron Life Sciences Corp.: Khiron Life Sciences Agrees to $500,000 Secured Deposit
June 5, 2023 | finance.yahoo.com
Khiron Life Sciences Agrees to $500,000 Secured Deposit
May 6, 2023 | finance.yahoo.com
KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER
April 20, 2023 | finance.yahoo.com
Khiron Completes First Phase of Business Optimization
October 3, 2023 | Wall Street Fundamentals (Ad)
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
April 17, 2023 | msn.com
Khiron Life Sciences CFO Helen Bellwood to be replaced by Michael O'Connor
April 17, 2023 | finance.yahoo.com
KHIRON LIFE SCIENCES ANNOUNCES NEW CFO
April 17, 2023 | finance.yahoo.com
Take Care Before Jumping Onto Khiron Life Sciences Corp. (CVE:KHRN) Even Though It's 47% Cheaper
April 12, 2023 | theglobeandmail.com
Closing Bell: Khiron Life Sciences Corp WT down on Monday (KHRN-WT)
March 24, 2023 | benzinga.com
Khiron Stock Trading Lower On Announcing Pricing Of Marketed Offering Of Units
March 24, 2023 | finance.yahoo.com
KHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITS
March 16, 2023 | marketwatch.com
Khiron Life Sciences Shares Drop 28% on Overnight Offering
February 17, 2023 | seekingalpha.com
KHRNF Khiron Life Sciences Corp.
February 16, 2023 | finance.yahoo.com
Khiron Closes Additional Loan with Investment-Grade Bank
February 14, 2023 | finance.yahoo.com
Khiron Closes Revolving Credit Facility with Financing Company in Colombia
January 18, 2023 | proactiveinvestors.com
Khiron Life Sciences shares growth in medical cannabis field throughout South America and Europe
January 9, 2023 | finanznachrichten.de
Khiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance company
December 1, 2022 | finance.yahoo.com
Khiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)
November 30, 2022 | seekingalpha.com
Khiron Life Sciences Corp. (KHRNF) Q3 2022 Earnings Call Transcript
November 30, 2022 | finanznachrichten.de
Khiron Life Sciences Corp.: Khiron Life Sciences Reports Third Quarter 2022 Financial Results
November 30, 2022 | finance.yahoo.com
Khiron Life Sciences Reports Third Quarter 2022 Financial Results
November 18, 2022 | finance.yahoo.com
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
November 16, 2022 | finanznachrichten.de
Khiron Life Sciences Corp.: Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom
See More Headlines
Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

KHRNF Company Calendar

Today
10/03/2023
Next Earnings (Estimated)
11/28/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:KHRNF
CUSIP
N/A
CIK
N/A
Web
www.khiron.ca
Phone
(702) 527-3564
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover
The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Alvaro Francisco Torres (Age 44)
    Co-Founder, CEO & Director
    Comp: $201.6k
  • Ms. Franziska Katterbach
    Pres of Khiron Europe
  • Mr. Swapan Kakumanu ACA (Age 53)
    ACWA, CGA, Corp. Sec.
    Comp: $44.32k
  • Mr. Michael John O'Connor MA (Age 56)
    Chief Financial Officer
  • Mr. Manuel Buendia
    VP of Operations
  • Mr. Marco Algorta
    Country Mang. of Uruguay

Key Competitors

View All Competitors













KHRNF Stock - Frequently Asked Questions

Should I buy or sell Khiron Life Sciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" KHRNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KHRNF, but not buy additional shares or sell existing shares.
View KHRNF analyst ratings or view top-rated stocks.

How have KHRNF shares performed in 2023?

Khiron Life Sciences' stock was trading at $0.0415 on January 1st, 2023. Since then, KHRNF stock has decreased by 74.7% and is now trading at $0.0105.
View the best growth stocks for 2023 here.

Are investors shorting Khiron Life Sciences?

Khiron Life Sciences saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 146,000 shares, a decline of 9.8% from the August 31st total of 161,900 shares. Based on an average trading volume of 336,300 shares, the days-to-cover ratio is currently 0.4 days.
View Khiron Life Sciences' Short Interest.

When is Khiron Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 28th 2023.
View our KHRNF earnings forecast.

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.01.

How can I contact Khiron Life Sciences?

Khiron Life Sciences' mailing address is 500 Burrard Street, Vancouver, BC V6C. The official website for the company is www.khiron.ca. The company can be reached via phone at (702) 527-3564.

This page (OTCMKTS:KHRNF) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -